Literature DB >> 33846607

How could a COVID vaccine cause blood clots? Scientists race to investigate.

Heidi Ledford.   

Abstract

Entities:  

Keywords:  Immunology; Infection; SARS-CoV-2; Vaccines

Mesh：

Substances：

Year:  2021        PMID： 33846607     DOI： 10.1038/d41586-021-00940-0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  2 in total

1.  Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.

Authors:  Nina H Schultz; Ingvild H Sørvoll; Annika E Michelsen; Ludvig A Munthe; Fridtjof Lund-Johansen; Maria T Ahlen; Markus Wiedmann; Anne-Hege Aamodt; Thor H Skattør; Geir E Tjønnfjord; Pål A Holme
Journal:  N Engl J Med       Date:  2021-04-09       Impact factor: 91.245

2.  Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.

Authors:  Andreas Greinacher; Thomas Thiele; Theodore E Warkentin; Karin Weisser; Paul A Kyrle; Sabine Eichinger
Journal:  N Engl J Med       Date:  2021-04-09       Impact factor: 91.245
  2 in total
  11 in total

Review 1.  COVID-19: vaccination problems.

Authors:  Harald Brüssow
Journal:  Environ Microbiol       Date:  2021-05-14       Impact factor: 5.476

2.  Signal transduction pathway involved in platelet activation in immune thrombotic thrombocytopenia after COVID-19 vaccination.

Authors:  Roberta Misasi; Antonella Capozzi; Gloria Riitano; Serena Recalchi; Valeria Manganelli; Vincenzo Mattei; Agostina Longo; Manuela De Michele; Tina Garofalo; Fabio M Pulcinelli; Maurizio Sorice
Journal:  Haematologica       Date:  2022-01-01       Impact factor: 9.941

3.  The Pfizer-BNT162b2 mRNA-based vaccine against SARS-CoV-2 may be responsible for awakening the latency of herpes varicella-zoster virus.

Authors:  M D Maldonado; J Romero-Aibar
Journal:  Brain Behav Immun Health       Date:  2021-10-30

Review 4.  COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review.

Authors:  Faizan Zarreen Simnani; Dibyangshee Singh; Ramneet Kaur
Journal:  3 Biotech       Date:  2021-12-12       Impact factor: 2.406

5.  Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry.

Authors:  Behnood Bikdeli; David Jiménez; Pablo Demelo-Rodriguez; Francisco Galeano-Valle; José Antonio Porras; Raquel Barba; Cihan Ay; Radovan Malý; Andrei Braester; Egidio Imbalzano; Vladimir Rosa; Ramón Lecumberri; Carmine Siniscalchi; Ángeles Fidalgo; Salvador Ortiz; Manuel Monreal
Journal:  Viruses       Date:  2022-01-18       Impact factor: 5.048

6.  Understanding hesitancy with revealed preferences across COVID-19 vaccine types.

Authors:  Kristóf Kutasi; Júlia Koltai; Ágnes Szabó-Morvai; Gergely Röst; Márton Karsai; Péter Biró; Balázs Lengyel
Journal:  Sci Rep       Date:  2022-08-02       Impact factor: 4.996

Review 7.  Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations.

Authors:  Sally A Helmy; Rasha M El-Morsi; Soha A M Helmy; Soha M El-Masry
Journal:  J Drug Deliv Sci Technol       Date:  2022-09-08       Impact factor: 5.062

8.  New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine.

Authors:  Yasser Aladdin; Bader Shirah
Journal:  J Neuroimmunol       Date:  2021-06-07       Impact factor: 3.478

Review 9.  The Rise of Vectored Vaccines: A Legacy of the COVID-19 Global Crisis.

Authors:  Danielle Soares de Oliveira Daian E Silva; Flávio Guimarães da Fonseca
Journal:  Vaccines (Basel)       Date:  2021-09-29

10.  A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates.

Authors:  Limin Yang; Deyu Tian; Jian-Bao Han; Wenhui Fan; Yuan Zhang; Yunlong Li; Wenqiang Sun; Yanqiu Wei; Xiaodong Tian; Dan-Dan Yu; Xiao-Li Feng; Gong Cheng; Yuhai Bi; Yong-Tang Zheng; Wenjun Liu
Journal:  Innovation (N Y)       Date:  2021-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.